There are currently 31 active clinical trials seeking participants for Healthy Participants research studies. The states with the highest number of trials for Healthy Participants participants are California, Florida, Texas and Maryland.
A Study to Assess the Effects of BPN14770 on Rosuvastatin
NCT07011992
Recruiting
The primary objective of this study is to investigate the effects of BPN14770 on the pharmacokinetics of the breast cancer resistance protein and organic anion transporting polypeptide 1B1 substrate rosuvastatin in healthy adults.
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
07/29/2025
Locations: ICON Clinical Research, Lenexa, Kansas
Conditions: Healthy Participants
Register for Updates
A Study to Assess the Tolerability and Safety of Subcutaneously (SC) Administered Immunoglobulin G (IgG) With Varying Injection Conditions
NCT07025577
Recruiting
This study will evaluate the safety and tolerability of SC administration of IgG in healthy participants.
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
07/25/2025
Locations: Daytona Beach Clinical Rsch Unit, Daytona Beach, Florida +2 locations
Conditions: Healthy Participants
Register for Updates
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
NCT07095426
Recruiting
Based on prior research, the investigators are interested in whether an intervention targeting gut health (supplemental fiber for 9 weeks total) will improve vascular health in individuals with obesity. Additionally, the investigators are interested in if this response differs based on whether individuals with obesity have very few heart disease risk factors or several heart disease risk factors.
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
07/24/2025
Locations: Health Professions Building, Muncie, Indiana
Conditions: Metabolic Syndrome, Healthy Participants, Metabolically Healthy Obesity, Metabolically Abnormal Obesity
Register for Updates
A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating Women
NCT06961747
Recruiting
The purpose of this study is to assess the steady state (SS) concentrations of zilucoplan (ZLP) and its major metabolites in mature breast milk of healthy study participants following njection of repeated once-daily doses of ZLP.
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
07/16/2025
Locations: UP0137 2, San Antonio, Texas +1 locations
Conditions: Healthy Participants
Register for Updates
Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB000631 When Administered Orally to Healthy Adult Participants
NCT07039929
Recruiting
This study will be conducted to assess the safety, tolerability, and pharmacokinetics of INCB000631 when administered orally to healthy adult participants.
Gender:
ALL
Ages:
Between 19 years and 55 years
Trial Updated:
07/16/2025
Locations: Celerion, Inc, Lincoln, Nebraska
Conditions: Healthy Participants
Register for Updates
A Study of the Pharmacokinetic Interaction Between Pirfenidone, Nintedanib, and Nalbuphine Extended Release (NAL ER) in Healthy Participants
NCT07015398
Recruiting
The primary purpose of this study is to evaluate the effect of steady-state NAL ER on the pharmacokinetics (PK) of pirfenidone or nintedanib and the effect of steady-state pirfenidone or nintedanib on the PK of NAL ER in healthy participants.
Gender:
ALL
Ages:
Between 18 years and 60 years
Trial Updated:
07/16/2025
Locations: Clinical Pharmacology of Miami, Miami, Florida
Conditions: Healthy Participants
Register for Updates
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels
NCT06980428
Recruiting
The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single and multiple ascending doses of AZD4954 in healthy participants with or without elevated Lipoprotein(a) (Lp\[a\]) levels.
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
07/15/2025
Locations: Research Site, Glendale, California +3 locations
Conditions: Healthy Participants
Register for Updates
A Study to Determine the Safety and Tolerability of AG-236 and How it is Absorbed, Broken Down, and Eliminated From the Body in Healthy Participants
NCT07075640
Recruiting
The primary purpose of this study is to assess the safety and tolerability of a single dose of AG-236 administered subcutaneously in healthy participants.
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
07/11/2025
Locations: Fortrea Clinical Research Unit Inc., Madison, Wisconsin
Conditions: Healthy Participants
Register for Updates
A Study to Assess the Time to Onset of Action of Staccato Alprazolam Versus Midazolam and Diazepam in Healthy Participants
NCT07020988
Recruiting
The purpose of this study is to estimate the difference in the time to onset of action between Staccato alprazolam and intravenous (iv) midazolam using changes in power in the combined spindle and β1 frequency bands in the qEEG (quantitative electroencephalogram).
Gender:
ALL
Ages:
Between 20 years and 55 years
Trial Updated:
07/10/2025
Locations: Up0127 1001, Glendale, California
Conditions: Healthy Participants
Register for Updates
A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants
NCT07018635
Recruiting
This study is conducted to assess the effect of itraconazole, rifampin, and acid-reducing agents on INCB161734 pharmacokinetics when administered orally in healthy participants.
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
07/09/2025
Locations: Fortrea Clinical Research Unit Ltd Labcorp Clinical Research Unit Limited Madison, Madison, Wisconsin
Conditions: Healthy Participants
Register for Updates
A Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD8965 in Healthy Participants (Including Japanese and Chinese Participants) and an Open-label Cohort to Assess the Effect of Food on the Pharmacokinetics of AZD8965 in Healthy Participants
NCT06502379
Recruiting
The purpose of this study is to assess the safety, tolerability, and pharmacokinetics (PK) of AZD8965 via single and multiple ascending doses in healthy participants (including Japanese and Chinese participants), and to assess the effect of food on the safety, tolerability, and PK of orally administered AZD8965.
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
07/09/2025
Locations: Research Site, Glendale, California
Conditions: Healthy Participants
Register for Updates
An Accessorised Prefilled Syringe to an Autoinjector Pharmacokinetic Bridging Study of Tozorakimab
NCT06908577
Recruiting
The purpose of this study is to compare the pharmacokinetic (PK) exposures of a single subcutaneous (SC) dose of tozorakimab administered using AI or APFS in healthy participants.
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
07/07/2025
Locations: Research Site, Glendale, California +3 locations
Conditions: Healthy Participants
Register for Updates